Brief: Qualigen Therapeutics Says Co Granted Until Oct 31, 2024 To Regain Compliance With Nasdaq Rules
05/08/2024 23:30
Aug 5 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS : GRANTED UNTIL OCT 31, 2024 TO
REGAIN
COMPLIANCE WITH NASDAQ RULES
Source text for Eikon: ID:n0001493152-24-030244
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise